Sinocelltech Group Limited(688520),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

688520 Sinocelltech Group Limited

Closed 12-12 15:00:00

46.55

-0.48

-1.02%

High47.16	Low46.05	Vol4.90M
Open47.16	D1 Closing47.03	Amplitude2.36%
Mkt Cap20.71B	Tradable Cap20.71B	Total Shares445.00M
T/O228.00M	T/O Rate1.10%	Tradable Shares445.00M
P/B-28.63	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"688520","market":"SH","secType":"STK","nameCN":"Sinocelltech Group Limited","latestPrice":46.55,"timestamp":1765522800000,"preClose":47.03,"halted":0,"volume":4904631,"delay":0,"changeRate":-0.0102,"floatShares":445000000,"shares":445000000,"eps":-0.6483,"marketStatus":"Closed","change":-0.48,"latestTime":"12-12 15:00:00","open":47.16,"high":47.16,"low":46.05,"amount":228000000,"amplitude":0.0236,"askPrice":46.58,"askSize":15,"bidPrice":46.55,"bidSize":102,"shortable":0,"etf":0,"ttmEps":-0.6483,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":47.03,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":51.73,"lowLimit":42.33,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":445335714,"isCdr":false,"pbRate":-28.63,"roa":"--","roe":"0.0%","epsLYR":0.24,"committee":0.315217,"marketValue":20730000000,"turnoverRate":0.011,"status":1,"afterMarket":{"amount":9310,"volume":200,"close":46.55,"buyVolume":1673,"sellVolume":0,"time":1765524839585,"indexStatus":"Closed 12-12 15:30:00","preClose":47.03},"floatMarketCap":20730000000},"requestUrl":"/m/hq/s/688520","defaultTab":"news","newsList":[{"id":"2590734501","title":"Sinocelltech Group  Says Co and Controlling Shareholder Plan to Boost Capital in Unit by 3 Bln Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2590734501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590734501?lang=en_us&edition=fundamental","pubTime":"2025-12-12 21:46","pubTimestamp":1765547207,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4N3XI0YO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2590501762","title":"BRIEF-Sinocelltech Group And Controlling Shareholder Plan To Boost Capital In Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2590501762","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590501762?lang=en_us&edition=fundamental","pubTime":"2025-12-12 21:46","pubTimestamp":1765547207,"startTime":"0","endTime":"0","summary":"BRIEF-Sinocelltech Group And Controlling Shareholder Plan To Boost Capital In Unit  Dec 12  - Sinocelltech Group Ltd 688520.SS:SAYS CO AND CONTROLLING SHAREHOLDER PLAN TO BOOST CAPITAL IN UNIT BY 3 BILLION YUAN Source textFurther company coverage: 688520.SS  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4N3XI0YO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688520","BK0239"],"gpt_icon":0},{"id":"1146885724","title":"Sinocelltech Group Limited Raises 900 Million Yuan to Boost Liquidity, Responds to Subsidizing Patients as Industry Norm","url":"https://stock-news.laohu8.com/highlight/detail?id=1146885724","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146885724?lang=en_us&edition=fundamental","pubTime":"2025-10-15 22:50","pubTimestamp":1760539846,"startTime":"0","endTime":"0","summary":"On October 15, Sinocelltech Group Limited (688520.SH) announced a plan to raise up to 900 million yuan through a private placement to supplement its liquidity. In response to recent inquiries from...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688520","BK0239"],"gpt_icon":0},{"id":"1168793876","title":"Sinocelltech Group Limited (688520.SH) Reports Half-Year Results with Net Loss of 33.77 Million Yuan, Turning from Profit to Loss Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1168793876","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168793876?lang=en_us&edition=fundamental","pubTime":"2025-08-28 18:24","pubTimestamp":1756376689,"startTime":"0","endTime":"0","summary":"Sinocelltech Group Limited (688520.SH) disclosed its 2025 half-year report. During the reporting period, the company achieved revenue of 972 million yuan, a year-over-year decrease of 25.50%; net...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688520","BK0239"],"gpt_icon":0},{"id":"1114305067","title":"Sinocelltech Faces Crisis: Flagship Product Implicated in Medical Insurance Fraud as Innovation Drug Companies Navigate Healthcare Policy Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=1114305067","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114305067?lang=en_us&edition=fundamental","pubTime":"2025-08-27 17:41","pubTimestamp":1756287703,"startTime":"0","endTime":"0","summary":"A criminal judgment has exposed the hidden corners of innovative pharmaceutical company Sinocelltech Group Limited. A recent judgment (No. 2025 Zhe 038 Criminal First Instance 676) published by the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1161","06978","BK1574","688520","BK0239"],"gpt_icon":0},{"id":"2554198754","title":"Sinocelltech Subsidiary Gets China Clinical Trial Nod for Rheumatoid Arthritis Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2554198754","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554198754?lang=en_us&edition=fundamental","pubTime":"2025-07-25 15:43","pubTimestamp":1753429394,"startTime":"0","endTime":"0","summary":"China's drug administrator approved Sinocelltech (SHA:688520) subsidiary Beijing Sinocell Biotechnology Group's clinical trial for its SCT640C injection for rheumatoid arthritis, according to a Friday filing with the Shanghai bourse.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2546764812","title":"Sinocelltech Subsidiary Gets Clinical Trial Approval for Anti-Tumor Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2546764812","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546764812?lang=en_us&edition=fundamental","pubTime":"2025-06-26 10:21","pubTimestamp":1750904491,"startTime":"0","endTime":"0","summary":"Chinese authorities allowed Sinocelltech  subsidiary Beijing Sinocell Biotechnology to conduct clinical trials for the SCTB39G injection for advanced solid tumors, according to a Thursday filing with the Shanghai bourse.The injection is a multi-target immunotherapy trispecific antibody injection, the filing said.Shares in the drug company slipped 2% during morning trading on Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2544943633","title":"Sinocelltech Receives Clinical Trial Approval for Multi-Target Immunotherapy in Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2544943633","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544943633?lang=en_us&edition=fundamental","pubTime":"2025-06-18 10:35","pubTimestamp":1750214149,"startTime":"0","endTime":"0","summary":"Sinocelltech Group  has received approval from China's National Medical Products Administration for the clinical trial of its independently developed product, SCTB39-1 injection.The NMPA has agreed for the SCTB39-1 injection to proceed with clinical trials as a monotherapy in patients with advanced malignant solid tumors, according to a Shanghai Stock Exchange filing on Wednesday.SCTB39-1 is described as a multi-target immunotherapy trispecific antibody injection for cancer treatment.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688520","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-06-22","address":"北京市大兴区北京经济技术开发区科创七街31号院5号楼307","stockEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":-0.072},{"period":"3month","weight":-0.2242},{"period":"6month","weight":-0.0488},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.2848}],"companyName":"北京神州细胞生物技术集团股份公司","boardCode":"AI0027","perCapita":"32390股","boardName":"医药制造业","registeredCapital":"44533万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　北京神州细胞生物技术集团股份公司的主营业务是恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。公司的主要产品是SCT800（安佳因）、SCT400（安平希）、SCT630（安佳润）、SCT510（安贝珠）、SCT-I10A（安佑平）、SCT1000SCT650C、SCTC21C、SCTB35、SCTB14、SCTB41、SCTV02、SCTV04C、SCT520FF、SCTT11、SCTB39-1、SCTB39G、SCT640C。","serverTime":1765732923947,"listedPrice":25.64,"stockholders":"13749人(较上一季度增加40.96%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sinocelltech Group Limited(688520),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Sinocelltech Group Limited(688520) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Sinocelltech Group Limited,688520,Sinocelltech Group Limited股票,Sinocelltech Group Limited股票老虎,Sinocelltech Group Limited股票老虎国际,Sinocelltech Group Limited行情,Sinocelltech Group Limited股票行情,Sinocelltech Group Limited股价,Sinocelltech Group Limited股市,Sinocelltech Group Limited股票价格,Sinocelltech Group Limited股票交易,Sinocelltech Group Limited股票购买,Sinocelltech Group Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sinocelltech Group Limited(688520),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Sinocelltech Group Limited(688520) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}